Skip to main content
. 2021 Jul 21;13:17588359211018018. doi: 10.1177/17588359211018018

Figure 7.

Figure 7.

(a) Forest plots for indirect comparisons between anti-CTLA-4 and anti-PD-L1 agents according to efficacy and safety outcomes. (b) Along with subgroup. (c) Landmark survival analyses.

CI, confidence interval; PD-L1, programmed death ligand 1; CTLA-4, cytotoxic T lymphocyte-associated antigen-4; IV, inverse-variance; SE, standard error.